New book by Larry Connors Click here Improve your trading - See how
Mr. Whisenant has over 15 years' experience in both strategic marketing and sales advisory roles. After studying at the University of Arkansas at Little Rock (UALR), Mr. Whisenant founded and operated seven retail chain stores, which were eventually sold as he began consulting small to medium companies on how to achieve marketing goals. Mr. Whisenant is currently employed by a NASDAQ-listed corporation in which Mr. Whisenant is architecting new lines of business.
David Lee, digiMedical CEO, stated, "With Mr. Whisenant's robust retail, supply management and E-commerce experience, I know he will be able to provide incredible insight into how we can approach our new software model. One of Mr. Whisenant's first suggestions was to private label our products, a process which we have already begun. We are excited Mr. Whisenant has accepted this role, and we look forward to his input as we continue to make progress toward new ventures."
Jason Whisenant commented, "Mr. Lee and I have known each other almost 20 years, and I know the character and the determination he brings to digiMedical. I am excited to advise both Mr. Lee and digiMedical as the Company navigates the ever changing world of sales and marketing. It will take lots of energy and fortitude to move the Company's proven products into an E-commerce and private label market, nevertheless after visiting with the key management of the Company, I know we will be successful."
Separately, the Company recently launched a new interactive corporate website. The new site, www.digimedical.com, offers doctors, patients, pharmacists and investors a clear view of the company's technology, service offerings and current news and events. Utilizing the latest Microsoft technologies such as .NET, AJAX and Microsoft SQL, the Company has developed a suite of products to digitally manage the prescription process. The company's products comply with all HIPAA and DEA requirements for patient medical record security.
To be added to digiMedical's corporate e-mail list to receive company updates, please send an e-mail to ir@digimedical.com.
About digiMedical Solutions, Inc.(TM) (www.digiMedical.com)
digiMedical Solutions, Inc.(TM) is a pharmacy and medical technology company focused on developing next generation, digital medical technology with an emphasis on digital prescriptions (d-Prescriptions) that closely align the doctor, pharmacist and patient. The company's planned growth will come from three channels: direct marketing of the company's wireless based d-prescription technology to physicians, direct marketing of the company's digital call center services for refills and reauthorization and partnering with independent pharmacy chains to focus sales with the technology suite.
Forward-Looking Statement
Statements included in this press release which are not historical in nature, are intended to be, and are hereby identified as "Forward-Looking Statements" for purposes of safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended. Forward-Looking Statements may be identified by words including "anticipate," "await," "envision," "foresee," "aim at," "believe," "intends," "estimates" including without limitation, those relating to the company's future business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the Forward-Looking Statements. Readers are directed to the company's filings with the U.S. Securities and Exchange Commission.
Contact: digiMedical Solutions, Inc. Investor Relations 214-722-3029 ir@digimedical.com www.digimedical.com
SOURCE: digiMedical Solutions, Inc.
mailto:ir@digimedical.com http://www.digimedical.com
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
